Industrials · Industrial - Machinery · Synthos Deep Dive · 2026-07-03
| Verdict | Watch — systematic Synthos tier |
| Price (2026-07-02) | $213.71 · market cap ~$28.8B |
| Synthos scores (0–10) | Downside Risk 4 · Growth Quality 6 · Exponential Potential 3 |
| Synthos fair value (base case) | ~$235 → +10% · full range $175 (bear) – $290 (bull) |
| Street consensus | $242.73 (high $279 / low $205; median $250; 18 Buy · 10 Hold · 0 Sell) — context, not our anchor |
| Valuation | 26.5× trailing EPS · ~20× FY26E · ~18× FY27E · ~15× FY29E · EV/S 3.7× · EV/EBITDA 16.2× |
| Exponential Potential | 3/10 · Low — ~5% revenue growth, ~10-12% EPS CAGR via margin/mix and buybacks; mature $29B cap, no acceleration |
| Technicals | Mixed — $213.71, −8.4% off 52-wk high, below 50-DMA, above 200-DMA, RSI 45, +14.8% 12-mo (SPY +20.6%) |
| Conviction | Low — 0 Synthos KB claims (no expert coverage); call rests on fundamentals + quant |
| Position sizing | If owned, a ~1-3% diversified-industrial holding; not a high-conviction overweight |
| Next catalyst | 2026-07-23 Q2'26 earnings (Street EPS $2.72, revenue ~$2.21B) |
| Single biggest risk | Industrial cyclicality — a capex/demand downturn compresses both earnings and the multiple |
One-line thesis. Dover is a well-run, low-leverage, five-segment diversified industrial (FY25 revenue $8.09B, adjusted continuing EPS ~$8.01, book-to-bill above one in all five segments) that is quietly re-mixing toward secular-growth end markets — but at ~20× forward earnings on ~5% organic growth it is priced roughly for what it is, so we start it as a Watch rather than a Buy.
Dover is a diversified manufacturer — it makes a huge range of industrial gear: fuel-station and EV-charging equipment, refrigeration cases for supermarkets, pumps, product-marking and coding machines, and automation parts. Think of it as five different mid-sized machine companies bundled under one roof, which smooths out the bumps when any one market slows.
The business is solid and financially healthy — low debt, steady cash generation, and management is shifting the mix toward faster-growing niches (clean-energy fueling, biopharma pumps, CO2 refrigeration). But the stock is priced about fairly: you're paying roughly $20 for every $1 of next year's expected profit, which is reasonable but not a bargain, and the underlying business only grows sales about 5% a year.
Our verdict is Watch — a quality company we'd happily own on a pullback, but not cheap enough today to chase.
Here's what our three scores mean in everyday terms:
The one big worry: Dover's customers are factories, fuel retailers, and supermarkets. When the economy slows and businesses stop spending on equipment, Dover's orders and profits fall — and the stock usually falls faster.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Above 70 (red band) = overbought, below 30 (green band) = oversold. Currently 43.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Solid = DOV · dashed = S&P 500 · dotted = XLI (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
Dover Corporation (NYSE: DOV) is a ~78-year-old diversified global manufacturer headquartered in Downers Grove, Illinois, with ~24,000 employees. It supplies industrial equipment, components, consumables, aftermarket parts, and software/digital platforms across five operating segments. CEO Richard J. Tobin has led a portfolio re-shaping toward higher-growth, higher-margin secular end markets. Fiscal year ends December 31.
Revenue mix (FY2025, from FMP segmentation):
| Segment | FY25 Revenue | ~% of total | What it does |
|---|---|---|---|
| Clean Energy & Fueling | $2.13B | 26% | Fuel-station & EV-charging hardware, cryo/hydrogen components, retail-fueling systems |
| Pumps & Process Solutions | $2.15B | 27% | Specialty pumps, connectors, biopharma single-use, polymer processing, thermal connectors |
| Climate & Sustainability Technologies | $1.56B | 19% | Commercial refrigeration cases/doors, CO2 systems, heat exchangers |
| Imaging & Identification | $1.17B | 15% | Marking & coding, serialization, brand protection, digital textile printing |
| Engineered Products | $1.09B | 13% | Vehicle-service (aftermarket), waste handling, industrial automation, aerospace/defense |
The strategic through-line management emphasizes: rotating capital toward secular-growth-exposed end markets — clean-energy/hydrogen fueling, biopharma/single-use pumps, CO2 refrigeration, and thermal-connector components tied to data-center cooling — while keeping the cyclical legacy base as a cash engine.
There is no expert coverage of Dover in the Synthos knowledge base: total_claims = 0, breadth = 0, net conviction = 0. No net-bullish or cautionary voices have been distilled for this name. That is an honest gap, not a hidden signal — Dover is a quality mid-cap industrial that simply has not surfaced in the podcast/interview corpus the Synthos KB is built from.
Consequently, this verdict is entirely fundamentals- and quant-driven. Every number below traces to the FMP financials, analyst-estimate, and price data (labeled where forward/estimated) or to management's own SEC 8-K earnings release (§9, half-weighted). We cite zero claim_id values because there are zero claims — fabricating conviction here would violate the house standard.
The external read we can cite is the sell-side, offered as context only: 18 Buy / 10 Hold / 0 Sell, consensus rating "Buy," price-target consensus $242.73 (median $250, high $279, low $205). FMP's letter rating is B (overall score 3/5). We treat these as context, not as our anchor.
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 4 · Low-Moderate | Net-debt/EBITDA 0.88×, interest coverage 12×, current ratio 1.87 — a sturdy balance sheet. Offsets: beta 1.17, industrial cyclicality, and ~20× forward leaves modest cushion. |
| Growth Quality | 6 · Good | Forward EPS CAGR ~10-12% (FY25 ~$8.01 → FY29E $14.25) on ~5% revenue growth; gross margin 39.5% and rising, ROIC ~9.4%, ROE 14.7%. Quality mix shift, but top-line is modest. |
| Exponential Potential | 3 · Low | ~5% revenue growth with no acceleration; mature $29B cap in a fragmented but slow-growing industrial TAM. A compounder, not an exponential. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | Secular-mix shift accelerates; organic growth pushes toward 6-7%; margins expand with productivity + M&A. FY27E EPS beats to ~$12.5; multiple re-rates to ~23× as the market pays up for the higher-quality mix. | ~$290 (+36%) |
| Base (our anchor) | Estimates roughly hit — FY27E EPS ~$11.7; a ~10-12% EPS compounder with improving mix earns a ~20× forward multiple. | ~$235 (+10%) |
| Bear | Industrial downturn: organic growth stalls or turns negative, margins give back gains; FY27E EPS misses to ~$10.3; multiple de-rates to ~17× on cyclical fear. | ~$175 (−18%) |
Synthos fair value = the base case, ~$235 (+10%), with the full $175–$290 span as the honest range. This anchor sits below the Street's $242.73 consensus — we are slightly less generous on the forward multiple than the sell-side. This is a tracked call — the Forecaster Scorecard grades it once it matures.
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). DOV is a solid compounder with low exponential potential:
Exponential Potential: Low. Own DOV (if at all) for durable ~10-12% earnings compounding and a fortress balance sheet, not for a fast multibagger. This honest framing is why DOV is a Watch/diversified-holding candidate, not a satellite moonshot.
Dover is reasonably, not cheaply, valued. Trailing 26.5× EPS overstates richness because FY24's discontinued-ops gain distorts the trailing base; the cleaner read is forward: ~20× FY26E ($10.66), ~18× FY27E ($11.68), ~15× FY29E ($14.25). On enterprise value it is 16.2× EV/EBITDA and 3.7× EV/sales — a modest premium to the average diversified industrial, arguably warranted by the improving secular mix and 39.5% gross margin. FCF yield ~3.9%, dividend yield ~1.0% (payout only ~26%, so the dividend is very safe and growable). A reverse read: ~20× forward on a ~10-12% EPS grower implies a PEG near ~1.7-2.0 — full, not stretched. Street targets (context): consensus $242.73, high $279, low $205, median $250 — our $235 base FV sits just below consensus because we hold the forward multiple at ~20× rather than re-rating it. Not a value buy; a fairly-priced quality industrial.
Dover's moat is breadth + niche leadership + aftermarket/consumables: within each segment it holds strong positions in specialized, application-engineered products (fuel-dispensing systems, marking/coding consumables, biopharma single-use, CO2 refrigeration) where switching costs and a recurring consumables/aftermarket tail create stickiness. The diversified five-segment structure smooths cyclicality — book-to-bill was above one in all five segments in Q1'26 per management. It is not a wide-moat monopoly; it competes with strong diversified-industrial peers and its ~54% goodwill/intangibles base reflects that growth has been partly bought.
Peer set (market cap, from FMP): Ingersoll Rand $31.5B (closest diversified-industrial comp), Curtiss-Wright $28.1B, Hubbell $25.7B, Veralto $22.7B, AerCap $23.3B, Equifax $20.8B, IDEX $16.6B, ITT $16.7B, Howmet $108B, Pentair $12.4B. DOV sits mid-pack on multiple and growth — neither the cheapest nor the fastest-growing of the group, which is consistent with the Watch verdict.
Thesis tripwires (what would change the call): two consecutive quarters of negative organic growth or book-to-bill below one; gross-margin reversal; a large, dilutive/expensive acquisition; or a multiple re-rating above ~23× that removes the remaining upside (a signal to trim, not add).
Watch. Dover is a genuinely well-run, low-leverage, quality diversified industrial (FY25 revenue $8.09B, FCF $1.12B, net-debt/EBITDA 0.9×, Dividend King, book-to-bill above one in all five segments) that is patiently upgrading its mix toward secular-growth markets. The problem is not the business — it's the price and the pace: at ~20× forward on ~5% organic growth, the stock is roughly fairly valued, our base FV (~$235, +10%) sits just under the Street's $242.73, and there is no expert conviction in the KB to lean on. That combination is a Watch, not a Buy.
claim_ids are cited. This verdict is fundamentals- and quant-driven; fabricated conviction is structurally impossible (and here, explicitly absent).